Consistent with prior work demonstrating the importance of Alzheimer’s disease biomarkers and the AT(N) framework to cognitive performance,3,78,79 unadjusted relative importance analyses identified AT(N) group as the variable accounting for the most variance in cognition in the current study, followed by plasma NfL (Supplementary Fig. 1). The gene discussed is NEFL; the disease is Alzheimer disease.